世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000033999

強直性脊椎炎の世界市場規模調査・予測:薬剤クラス別、流通チャネル別、地域別の分析(2022年〜2029年)

Bizwit Research & Consulting LLP

Global Ankylosing Spondylitis Market Size study & Forecast, by Drug Class (NSAIDs, TNF Inhibitors and Others), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and Regional Analysis, 2022-2029

発刊日 2022/12/19

言語英語

体裁PDF/200ページ

ライセンス/価格200ページ

0000033999

Single
Enterprise (Global Site)

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

強直性脊椎炎の世界市場は、2021年に約53億8,000万米ドルと評価され、予測期間の2022年から2029年には4.6%を超える健全な成長率で成長すると予測されています。強直性脊椎炎は、脊椎の骨(椎骨)が癒合してしまう炎症性疾患を指します。この融合が背骨の柔軟性に影響し、姿勢が悪くなることがあり、肋骨が侵されると、深い呼吸が困難になることもあります。強直性脊椎炎の症状には、腰痛、臀部痛、肩こり、首の痛み、靭帯や腱の痛み、疲労感、寝汗などが含まれます。関節炎の有病率の増加、強直性脊椎炎の発生率の上昇、および主要な市場プレーヤーの戦略的イニシアチブは、市場の成長を加速させる主要因となっています。

関節炎の有病率の上昇は、世界の強直性脊椎炎市場の成長に寄与しています。例えば、関節炎財団(Arthritis Foundation)の推定によると、2019年現在、世界的に5400万人以上の大人と約30万人の子供が関節炎または別のタイプのリウマチ性疾患に罹患しています。さらに、強直性脊椎炎の発生率の増加も、本市場の成長を加速させています。例えば、米国脊椎炎協会(Spondylitis Association of America)によると、2020年現在、アメリカでは170万人以上の成人が強直性脊椎炎に罹患しています。一方、約320万人が軸性脊椎関節炎を患っています。また、整形外科病院や診断センターの数が増加していることや、新興国での医療インフラの整備が進んでいることも、予測期間中の市場の有利な成長見通しを生み出すと考えられます。しかし、強直性脊椎炎に関連する高い治療費は、2022年から2029年の予測期間を通じて市場の成長を阻害します。

強直性脊椎炎の世界市場の調査対象地域は、アジア太平洋地域、北アメリカ、ヨーロッパ、ラテンアメリカ、その他の地域です。北アメリカは、強直性脊椎炎の有病率の上昇や地域の医療インフラの成長などの要因により、市場シェアの面で主要な地域となっています。一方、アジア太平洋地域は、高齢者の増加やヘルスケアインフラの整備などの要因により、予測期間中に最も高いCAGRで成長すると予想されています。

調査範囲

  • 調査企業
    ➣ AbbVie Inc.
    ➣ Amgen, Inc,
    ➣ Eli Lilly and Company
    ➣ Gilead Sciences Inc.
    ➣ Janssen Pharmaceuticals
    ➣ Merck & Co. Inc
    ➣ Novartis AG,
    ➣ Pfizer, Inc
    ➣ Reliance Life Sciences Pvt. Ltd
    ➣ UCB, Inc.
  • 調査対象年
    ➣ 実績データ - 2019年、2020年、2021年
    ➣ 基準年 - 2021年
    ➣ 予測期間 - 2022年から2029年

本調査の目的は、近年における様々なセグメント・国の市場規模を定義し、今後数年間の価値を予測することです。本レポートは、調査対象国における産業の質的・量的な側面を取り込むように設計されています。

さらに、市場の今後の成長を決定づける推進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競争環境と製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。

  • 市場セグメント・サブセグメント
    ➣ 薬剤クラス別
      ◇ 非ステロイド性抗炎症薬(NSAID)
      ◇ TNF阻害薬
      ◇ その他
    ➣ 流通チャネル別
      ◇ 病院薬局
      ◇ 小売薬局
      ◇ オンライン薬局
    ➣ 地域別
      ◇ 北アメリカ
       ✓ アメリカ
       ✓ カナダ
      ◇ ヨーロッパ
       ✓ イギリス
       ✓ ドイツ
       ✓ フランス
       ✓ スペイン
       ✓ イタリア
       ✓ その他のヨーロッパ
      ◇ アジア太平洋地域
       ✓ 中国
       ✓ インド
       ✓ 日本
       ✓ オーストラリア
       ✓ 韓国
       ✓ その他のAPAC
      ◇ ラテンアメリカ
       ✓ ブラジル
       ✓ メキシコ
       ✓ 世界のその他の地域

レポート詳細

目次

Table of Contents

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Ankylosing Spondylitis Market, by Region, 2019-2029 (USD Billion)
1.2.2. Ankylosing Spondylitis Market, by Drug Class, 2019-2029 (USD Billion)
1.2.3. Ankylosing Spondylitis Market, by Distribution Channel, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Ankylosing Spondylitis Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Ankylosing Spondylitis Market Dynamics
3.1. Ankylosing Spondylitis Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Growing prevalence of Arthritis.
3.1.1.2. Growing incidences of Ankylosing Spondylitis
3.1.1.3. Strategic initiatives from leading market players
3.1.2. Market Challenges
3.1.2.1. High treatment cost of Ankylosing Spondylitis
3.1.3. Market Opportunities
3.1.3.1. Growing number of orthopedic hospitals and diagnostic centers
3.1.3.2. Rising healthcare infrastructure in developing regions.

Chapter 4. Global Ankylosing Spondylitis Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Ankylosing Spondylitis Market, by Drug Class
6.1. Market Snapshot
6.2. Global Ankylosing Spondylitis Market by Drug Class, Performance - Potential Analysis
6.3. Global Ankylosing Spondylitis Market Estimates & Forecasts by Drug Class 2019-2029 (USD Billion)
6.4. Ankylosing Spondylitis Market, Sub Segment Analysis
6.4.1. NSAIDs
6.4.2. TNF inhibitors
6.4.3. Others

Chapter 7. Global Ankylosing Spondylitis Market, by Distribution Channel
7.1. Market Snapshot
7.2. Global Ankylosing Spondylitis Market by Distribution Channel, Performance - Potential Analysis
7.3. Global Ankylosing Spondylitis Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
7.4. Ankylosing Spondylitis Market, Sub Segment Analysis
7.4.1. Hospital pharmacy
7.4.2. Retail pharmacy
7.4.3. Online pharmacy

Chapter 8. Global Ankylosing Spondylitis Market, Regional Analysis
8.1. Ankylosing Spondylitis Market, Regional Market Snapshot
8.2. North America Ankylosing Spondylitis Market
8.2.1. U.S. Ankylosing Spondylitis Market
8.2.1.1. Drug Class breakdown estimates & forecasts, 2019-2029
8.2.1.2. Distribution Channel breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Ankylosing Spondylitis Market
8.3. Europe Ankylosing Spondylitis Market Snapshot
8.3.1. U.K. Ankylosing Spondylitis Market
8.3.2. Germany Ankylosing Spondylitis Market
8.3.3. France Ankylosing Spondylitis Market
8.3.4. Spain Ankylosing Spondylitis Market
8.3.5. Italy Ankylosing Spondylitis Market
8.3.6. Rest of Europe Ankylosing Spondylitis Market
8.4. Asia-Pacific Ankylosing Spondylitis Market Snapshot
8.4.1. China Ankylosing Spondylitis Market
8.4.2. India Ankylosing Spondylitis Market
8.4.3. Japan Ankylosing Spondylitis Market
8.4.4. Australia Ankylosing Spondylitis Market
8.4.5. South Korea Ankylosing Spondylitis Market
8.4.6. Rest of Asia Pacific Ankylosing Spondylitis Market
8.5. Latin America Ankylosing Spondylitis Market Snapshot
8.5.1. Brazil Ankylosing Spondylitis Market
8.5.2. Mexico Ankylosing Spondylitis Market
8.6. Rest of The World Ankylosing Spondylitis Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. AbbVie Inc.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Amgen, Inc,
9.2.3. Eli Lilly and Company
9.2.4. Gilead Sciences Inc
9.2.5. Janssen Pharmaceuticals
9.2.6. Merck & Co. Inc
9.2.7. Novartis AG,
9.2.8. Pfizer, Inc
9.2.9. Reliance Life Sciences Pvt. Ltd
9.2.10. UCB, Inc.,

Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

LIST OF TABLES
TABLE 1. Global Ankylosing Spondylitis Market, report scope
TABLE 2. Global Ankylosing Spondylitis Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Ankylosing Spondylitis Market estimates & forecasts by Drug Class 2019-2029 (USD Billion)
TABLE 4. Global Ankylosing Spondylitis Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
TABLE 5. Global Ankylosing Spondylitis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Ankylosing Spondylitis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Ankylosing Spondylitis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Ankylosing Spondylitis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Ankylosing Spondylitis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Ankylosing Spondylitis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Ankylosing Spondylitis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Ankylosing Spondylitis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Ankylosing Spondylitis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Ankylosing Spondylitis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. U.S. Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. Canada Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 19. Canada Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. UK Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 22. UK Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. Germany Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 25. Germany Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. France Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 28. France Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. Italy Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 31. Italy Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Spain Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 34. Spain Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. RoE Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 37. RoE Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. China Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 40. China Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. India Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 43. India Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. Japan Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 46. Japan Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. South Korea Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 49. South Korea Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. Australia Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 52. Australia Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. RoAPAC Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 55. RoAPAC Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. Brazil Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 58. Brazil Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Mexico Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 61. Mexico Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. RoLA Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 64. RoLA Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. Row Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 67. Row Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Ankylosing Spondylitis Market
TABLE 70. List of primary sources, used in the study of global Ankylosing Spondylitis Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES
FIG 1. Global Ankylosing Spondylitis Market, research methodology
FIG 2. Global Ankylosing Spondylitis Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Ankylosing Spondylitis Market, key trends 2021
FIG 5. Global Ankylosing Spondylitis Market, growth prospects 2022-2029
FIG 6. Global Ankylosing Spondylitis Market, porters 5 force model
FIG 7. Global Ankylosing Spondylitis Market, pest analysis
FIG 8. Global Ankylosing Spondylitis Market, value chain analysis
FIG 9. Global Ankylosing Spondylitis Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Ankylosing Spondylitis Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Ankylosing Spondylitis Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Ankylosing Spondylitis Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Ankylosing Spondylitis Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Ankylosing Spondylitis Market, regional snapshot 2019 & 2029
FIG 15. North America Ankylosing Spondylitis Market 2019 & 2029 (USD Billion)
FIG 16. Europe Ankylosing Spondylitis Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Ankylosing Spondylitis Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Ankylosing Spondylitis Market 2019 & 2029 (USD Billion)
FIG 19. Global Ankylosing Spondylitis Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

この商品のレポートナンバー

0000033999

TOP